Pseudomyxoma Peritonei (PMP) is a rare and complex condition characterized by the abnormal growth of mucinous (gelatinous) tumors in the peritoneum, the thin membrane lining the abdominal cavity. These tumors typically originate from the appendix but can also arise from other organs like the ovaries or colon.
PMP is known for its slow progression and tendency to spread throughout the abdomen, causing the accumulation of mucinous fluid. This buildup of gelatinous material puts pressure on nearby organs, leading to various symptoms such as abdominal pain, bloating, changes in bowel habits, and weight loss.
Diagnosis of PMP involves a combination of imaging tests, biopsies, and analysis of the mucinous fluid. Treatment options for PMP depend on the extent of tumor spread and may involve a combination of surgery, chemotherapy, and sometimes heated intraperitoneal chemotherapy (HIPEC).
Due to its rarity and complexity, PMP requires a multidisciplinary approach involving specialists in surgical oncology, medical oncology, and radiology to provide personalized care and management.